Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Desjardins Securities is the investment banking and brokerage division of Desjardins Group, the largest cooperative financial group in North America. The firm offers a comprehensive suite of financial services, including institutional equity research, corporate finance advisory, and securities trading. Although it is not a life sciences company, Desjardins Securities plays a vital role in the healthcare sector by providing capital markets support and strategic advisory to biotech and pharmaceutical firms. Their specialized healthcare equity research team provides in-depth analysis and valuation for a wide range of medical technology and drug development companies. The firm facilitates initial public offerings, secondary offerings, and mergers and acquisitions for growth-stage healthcare entities in Canada and internationally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Desjardins Securities.